Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 14 Clinical Trials
ID/Name Source Type
16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
NCT01948791 clinicaltrials.gov Clinical Trial
A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease
NCT01047579 clinicaltrials.gov Clinical Trial
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease
NCT01399125 clinicaltrials.gov Clinical Trial
A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.
NCT02989402 clinicaltrials.gov Clinical Trial
Alzheimer's Disease and Precision Medicine Research With American Indian and Alaska Native People
NCT03448601 clinicaltrials.gov Clinical Trial
Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
NCT00506415 clinicaltrials.gov Clinical Trial
Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.
NCT00731224 clinicaltrials.gov Clinical Trial
Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age
NCT02576639 clinicaltrials.gov Clinical Trial
Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia
NCT00099216 clinicaltrials.gov Clinical Trial
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
NCT00099242 clinicaltrials.gov Clinical Trial